Table 2.
Longitudinal Patient-Level Reports
| Data Element | Available in Table Format | Available in Chart Format | American Diabetes Association Recommendation |
|---|---|---|---|
| A1c level | x | x | x |
| Alanine aminotransferase (ALT) level | x | x | x |
| Aspartate aminotransferase (AST) level | x | x | x |
| Blood pressure | x | x | x |
| Body mass index (BMI) | x | x | x |
| Creatinine | x | x | |
| Estimated glomerular filtration rate (eGFR) | x | x | x |
| Eye screening | x | x | |
| Flu vaccine | x | x | |
| Foot screening | x | x | |
| Glucose | x | x | x |
| Hepatitis B vaccine | x | x | |
| High-density lipoprotein (HDL) | x | x | x |
| Low-density lipoprotein (LDL) | x | x | |
| Metabolic class attendance | x | ||
| Notes | x | ||
| Patient-reported compliance | x | ||
| PCV-13 (pneumococcal conjugate) vaccine | x | ||
| Physical activity | x | x | |
| PPSV-23 (pneumococcal polysaccharide) vaccine | x | x | |
| Prostate-specific antigen (PSA) | x | x | x |
| Psychological screening (Patient Health Questionnaire [PHQ-9]) | x | x | |
| Quality checklist | x | ||
| Recent hospitalizations | x | ||
| Smoking cessation | x | ||
| T4 (thyroxine) level | x | x | x |
| Tdap vaccine | x | ||
| Telephone follow-up | x | ||
| Thyroid-stimulating hormone (TSH) | x | x | x |
| Treatment | x | ||
| Triglycerides | x | x | x |
| Urine albumen to creatinine ratio | x | x | x |
| Waist measurement | x | x | |
| Zoster vaccine | x | x |